Compatibility of hypokalaemia caused by low-dose prednisolone plus abiraterone acetate therapy for metastatic castration-resistant prostate cancer

• Asıl Yazarlar: Shota Torii (Yazar), Aya Torii-Goto (Yazar), Tamaki Tanizawa (Yazar), Takashi Sakakibara (Yazar), Ryosuke Oguri (Yazar), Haruka Nagase (Yazar), Yuri Nakao (Yazar), Tomoyuki Hirashita (Yazar), Kuniaki Tanaka (Yazar), Norio Takimoto (Yazar), Takahiro Hayashi (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2024-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background This study aimed to investigate the relationship between low-dose prednisolone (PSL) and the incidence of hypokalaemia at abiraterone acetate (abiraterone) plus PSL combination therapy targeting Japanese patients with metastatic castration-resistant prostate cancer (mCRPC). Metho...